Document is current
Any future updates will be listed below
-
Authors
Kosaki, Yoshihiko
Nishizawa, Daisuke
Hasegawa, Junko
Yoshida, Kaori
Ikeda, Kazutaka https://orcid.org/0000-0001-8342-0278
Ichinohe, Tatsuya
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP16H06276 (AdAMS), JP22H04922 (AdAMS), JP17H04324, JP23K21457, JP17K08970, JP20K09259, JP19K19212)
- License Information
-
More Information
Article History
Received: 18 July 2024
Accepted: 10 September 2024
First Online: 27 September 2024
Declarations
:
: This study was approved by the Tokyo Dental College Ethics Committee (Tokyo, Japan; approval No. 919; February 13, 2019) and Tokyo Metropolitan Institute of Medical Science Ethics Committee (Tokyo, Japan; approval No. 18–46; March 7, 2019). All of the patients provided written informed consent before participating in this study.
: Not applicable.
: Kazutaka Ikeda received speaker’s fees from Sumitomo Dainippon Pharma Co., Ltd. (Osaka, Japan), Otsuka Pharmaceutical Co., Ltd. (Tokyo, Japan), Daiichi-Sankyo Company, Limited (Tokyo, Japan), Eisai Co., Ltd. (Tokyo, Japan), MSD K.K. (Tokyo, Japan), and TV Asahi Productions Co., Ltd. (Tokyo, Japan); consulting honoraria from Sumitomo Dainippon Pharma Co., Ltd. (Osaka, Japan), Atheneum Partners (Tokyo, Japan), Nippon Chemiphar Co., Ltd. (Tokyo, Japan), and VistaGen Therapeutics, Inc. (California, USA); and research grants from Asahi Kasei Pharma Corporation (Tokyo, Japan), all unrelated to this study. All other authors declare that they have no conflict of interest.
